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Direct mass spectrometric characterization of interactions between proteins and small hydro-
phobic ligands often poses a serious problem due to the complex instability in the gas phase.
We have developed a method that probes the efficacy of ligand–protein interactions indirectly
by monitoring changes in protein flexibility. The latter is assessed quantitatively using a
combination of charge state distribution analysis and amide hydrogen exchange under both
native and mildly denaturing conditions. The method was used to evaluate binding of a model
protein cellular retinoic acid binding protein I to its natural ligand all-trans retinoic acid (RA),
isomers 13-cis- and 9-cis-RA, and retinol, yielding the following order of ligand affinities:
All-trans RA  9-cis RA  13-cis RA, with no detectable binding of retinol. This order is in
agreement with the results of earlier fluorimetric titration studies. Furthermore, binding
energy of the protein to each of retinoic acid isomers was determined based on the measured
hydrogen exchange kinetics data acquired under native conditions. (J Am Soc Mass Spec-
trom 2003, 14, 506–515) © 2003 American Society for Mass Spectrometry
In the past decade, mass spectrometry has come toplay a major role in characterization of proteinstructure, dynamics and function [1–3]. Mass spec-
trometry is particularly useful to study protein–ligand
interactions, owing to its ability to determine ligand
composition and binding stoichiometry by direct mass
measurement of the protein–ligand complex following
its desorption from solution by means of electrospray
ionization (ESI) [1]. Furthermore, charge state distribu-
tions in the ESI spectra of folded and unfolded proteins
provide a useful tool to study protein conformation at
low resolution [4, 5] and its relationship to ligand
binding [6]. Proteins under native conditions show
narrow charge state distributions in mass spectra with a
small number of charges, whereas those under denatur-
ing conditions tend to have broader charge state distri-
bution with a higher number of charges. Thus, one can
monitor protein conformations present in solution at
equilibrium, and also kinetically during folding with
time-resolved ESI-MS [7, 8].
Mass spectrometry is also useful for characterizing
the interface regions within multimeric proteins. This is
usually achieved by applying either chemical cross-
linking [9] or amide hydrogen/deuterium exchange
(HDX) [2]. HDX/ESI-MS (or HDX/MALDI-MS) mea-
sures the change of deuterium content by monitoring
the mass change as a function of exchange time. Ex-
change rates of backbone amide protons are strongly
dependent on their environments: HDX is affected by
the involvement in hydrogen bonding and solvent
accessibility [10].
Although HDX has been successfully applied to
investigate protein–protein complexes with large inter-
faces [11], it is not readily possible to use this approach
for direct mapping of small ligand binding; when the
ligand is small there is a lack of efficient shielding from
solvent at the intermolecular interface. Small hydropho-
bic ligands present a particularly difficult case, as the
protein–ligand interaction in this case does not involve
formation of hydrogen bonds that can be readily de-
tected in HDX-MS experiments. Another experimental
challenge often posed by small hydrophobic ligands is
their facile dissociation from proteins in the gas phase.
Indeed, the removal of solvent molecules from the
protein–ligand complex environment (upon its desorp-
tion to the gas phase) reduces the entropy-driven hy-
drophobic interactions to short-range van der Waals
interactions, while long-range (electrostatic) interac-
tions become the major determinant of the protein ion
structure [12]. As a result, even very mild desorption
conditions often cause partial or complete complex
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dissociation in the gas phase, thus compromising the
quality of ESI-MS based stoichiometric assignments
[13].
In this paper we evaluate indirect mass spectromet-
ric methods to characterize binding of small hydropho-
bic retinoid ligands to a model protein, cellular retinoic
acid binding protein I (CRABP I). CRABP I is a member
of a family of small soluble intracellular proteins that
bind hydrophobic ligands such as fatty acids, lipids,
and retinoids [14]. This 15 kDa protein contains 136
residues which form two 5-stranded -sheets. The first
two strands are connected by a helix-turn-helix motif,
and all of others by reverse turns. The two -sheets are
packed orthogonally to form a solvent-filled -barrel.
The ligand-binding pocket, which physiologically
accommodates all-trans retinoic acid (RA) is located
inside the barrel (Figure 1). Importantly, the native
ligand all-trans retinoic acid (ATRA), binds CRABP I
predominantly by hydrophobic interactions, as the li-
gand forms ten contacts with non-polar side chains and
only one salt bridge [15]. The overall contribution to the
free energy of the protein–ligand complex formation in
solution was estimated to be in the range of 5–6
kcal/mol [16]. The ligand binding/release mechanism
by CRABP I has not been clearly established. A “portal”
model has been postulated, which invokes the notion of
a highly dynamic segment within the protein that
serves as an opening, thus allowing the entry of ligand
into the cavity [17, 18]. In CRABP I this portal region
constitutes the helix-turn-helix motif and two flanking
-hairpins. Reduced dynamics within this region in the
holo-form of the protein effectively inhibits dissociation
of the complex in solution [19].
We have previously demonstrated that such changes
in protein dynamics can be probed using a variety of
ESI-MS based strategies [20, 21]. Therefore, protein
backbone dynamics can serve as a reliable, although
indirect, gauge of complex formation in solution. Using
this approach, one can probe complex formation in
solution under near native conditions and at physiolog-
ical concentrations. In addition to ATRA, we have also
included in our studies a set of non-cognate (but
natural) retinoid ligands, retinoic acid isomers (9-cis-RA
and 13-cis-RA), and retinol. The hydrophobic skeletons
of the former two are altered sufficiently to introduce
significant disruption to the network of “native” hydro-
phobic contacts, thus reducing stability of the complex
as demonstrated by fluorescence titration [22]. Retinol,
the fourth ligand used in our studies, does not form a
complex with CRABP I [23]. We have been able to rank
all four ligands according to their CRABP I affinity by
monitoring protein dynamics measured by ESI-MS.
This mass spectrometry-based method may be a reason-
able alternative to NMR when high protein concentra-
tions can not be achieved and/or high molecular
weight of the protein places it beyond the reach of
high-resolution NMR measurements. The method may
find uses in aiding the design of therapeutically active
ATRA analogs with enhanced binding to CRABP I [24]
or other retinoid carriers [25].
Experimental
Materials
All retinoids used in this work were purchased from
Sigma-Aldrich (St. Louis, MO). CRABP I samples were
generously provided by Professor L.M. Gierasch (Uni-
versity of Massachusetts). The protein sample was
deuterated by replacing all labile hydrogen atoms with
deuterium in several cycles of dissolution in D2O and
acetic-d4 buffer solution, followed by lyophilization.
Methods
For the exchange experiments, dry protein was dis-
solved to a concentration of 1 mg/ml with D2O and
acetic-d4 buffer solution. Back-exchange was initiated
Figure 1. Ribbon diagram of cellular retinoic aicd binding protein I complexed with all-trans-retinoic
acid (PDB 1CBR) and the chemical structures of the three isomers of retinoic acid studied in this work.
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by diluting the protein solution 1:50 in a desired pH
level protiated buffer solution (10 mM ammonium
acetate). All retinoids were initially dissolved at 3 mM
concentration in methanol. Small aliquots of such solu-
tions [typically 1:500 (vol:vol) dilution] were added to a
1.2 M protein solution at pH 7 to maintain the meth-
anol level below 0.5%. The final molar ratio of RA to
protein was thus 5:1, unless specified otherwise. The
protein concentration was calculated from UV absorp-
tion at 280 nm using extinction coefficient 20,970 M1
cm1 [26]. The concentrations of retinoid stock solutions
were measured using an extinction coefficient of 45,000
M1 cm1 at 350 nm [27]. Composition of each retinoid
stock solution was monitored by HPLC (C18 column)
prior to each experiment to verify absence of isomeriza-
tion [28].
ESI-MS data were acquired using a JMS-700 MSta-
tion (JEOL, Tokyo, Japan) magnetic sector mass spec-
trometer. Samples were continuously infused into the
electrospray ionization source at a 5 l/min flow rate
with an aluminum foil protected syringe (to avoid
photo-isomerization of retinoids in solution). Mass
spectra were acquired by scanning the magnet at a 5
s/decade rate. Each recorded spectrum was an average
of 30–50 scans.
Results and Discussions
Evaluation of the Protein–Ligand Complex
Stability in the Gas Phase
In line with expectations, the ATRA–CRABP I complex
was found to be rather unstable in the gas phase, owing
to the mostly hydrophobic character of the interaction.
The relative ionic signal of the ligand-bound protein
was found to be highly sensitive to ESI source condi-
tions (orifice/ring lens voltage and desolvating plate/
orifice temperature). At high voltage and intermediate
temperature (180/300 V, 120/80 °C), only ions corre-
sponding to the mass of the apo-protein were observed
(Figure 2a). The protein–ligand complex ions were
detected only following simultaneous reduction of volt-
age and temperature (Figure 2b, c). Under the mildest
possible desolvating conditions (orifice/ring lens volt-
age 0/60 V and desolvating plate/orifice temperature
80/60 °C), complex ion peaks of only 1:1 stoichiometry
were observed (Figure 2d).
Interestingly, apo-protein ions are still observed in
the mass spectrum of an equimolar mixture of ATRA
and CRABP I, even under the mildest conditions ap-
plied. Further reduction of the source temperature to
ambient resulted in much lower S/N ratio, but did not
alter the intensity ratio of the apo- and holo-protein ions
(ca. 98%). The dissociation constant measured by fluo-
rescence titration (Kd  0.4 nM [22]) suggests that the
fraction of free (unbound) ligand in solution is less than
0.01%. It is clear, therefore, that dissociation of a signif-
icant proportion of the complex must occur in the gas
phase. Upon increasing of the molar ratio stepwise from
1:1 to 5:1 (RA:CRABP), the proportion of holo-protein
ions increased in the ESI spectrum, while the binding
stoichiometry remained 1:1 (data not shown). It appears
that the proportion of complex present in the ESI
spectra depends not only on ESI conditions but also on
the relative concentration of ligand. When the molar
ratio of RA:CRABP is 5:1, we were able to observe the
spectrum with 98% ligand-bound complex ions under
mild source conditions. In all further experiments,
therefore, the ligand:protein molar ratio was main-
tained at 5:1 to insure complete formation of the holo-
protein.
The correlation between the proportion of the com-
plex present in ESI spectra and the relative concentra-
tions of protein and ligand in solution often suggests
the possibility of non-specific protein–ligand interac-
tions [13]. However, non-specific interactions in the gas
phase are also likely to alter the observed stoichiometry
of the complex ion in a concentration-dependent man-
ner, a phenomenon not observed in the ATRA–CRABP
I mixtures presented here (vide infra).
ESI MS spectra of CRABP I in the presence of RA
isomers and retinol acquired at neutral pH are shown in
Figure 3. The proportion of the ligand-bound forms of
CRABP I (1:1 stoichiometry) is significant, although not
as high as the ATRA–CRABP I complex, as judged by
relative intensities of holo- and apo-protein ion intensi-
ties in the ESI spectra (Figure 3b, c). Alteration of the
Figure 2. ESI MS: Stability of the CRABP–RA complex ions in the
gas phase as a function of orifice 1/ring lens voltage (VO-L) and
desolvating plate/orifice 1 temperature (TD): VO-L  120 V, TD 
80 °C (a); VO-L  100 V, TD  80 °C (b); VO-L  60 V, TD  80 °C
(c); VO-L 60 V, TD 60 °C (d). CRABP-RA complex ion peaks are
marked with a filled square, apo-CRABP ion peaks are marked
with an open square.
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hydrophobic backbone in 9-cis RA and 13-cis RA dis-
rupts the hydrophobic protein–ligand contacts, while
the electrostatic portion is not affected. This weakens
the overall interaction, a fact confirmed by fluorimetric
titration [22]. Our measurements are consistent with
this notion, suggesting the following order of relative
affinities: ATRA  13-cis-RA  9-cis-RA. However, it is
noted that the ligand binding affinities of the two
isomers of retinoic acid to CRABP I are in the reversed
order as compared the results of fluorimetric studies:
ATRA  9-cis-RA  13-cis-RA [22, 29]. This suggests
that the protein–ligand complex stability in the gas
phase does not necessarily mirror the binding strength
in solution, particularly if hydrophobic interactions
play an important role. Complete elimination of the
hydrophobic skeleton of RA gives rise to non-specific
protein–ligand interactions, as evidenced by a range of
acetate adducts with varying stoichiometry present in
all ESI spectra acquired under mild conditions (Figure 3
inset).
A control ESI spectrum of CRABP I in the presence of
a five-fold molar excess of retinol (ROH) has been
obtained under the same ESI interface conditions as the
ATRA–CRABP I mixture. ROH has the same hydropho-
bic backbone as ATRA, but lacks a terminal carboxylate
group (Figure 1), which effectively eliminates binding
to CRABP I [23]. The spectrum of the ROH–CRABP I
mixture contains only protein ion peaks corresponding
to the apo-form of the protein (Figure 3d). However,
this observation should be approached with some skep-
ticism, as one might argue that even if the ROH–CRABP
I complex were formed in solution, it may not survive
the transition to the gas phase due to the absence of any
electrostatic interactions between the complex constitu-
ents. Clearly, one needs to devise an alternative strategy
in order to prove absence of binding in solution.
Protein Dynamics and Ligand Binding—HDX
Measurements at Neutral pH
Recent progress in the areas of protein folding and
binding has led to the realization that the two processes
should not necessarily be considered separately from
each other [30]. This notion is often used when studying
protein–protein interactions [31, 32], however, it can
also be very useful when protein interaction with small
organic ligands is considered. A common assumption
here is that binding reduces flexibility [33, 34], which
has been proven experimentally in the case of several
retinoid carriers [19, 35, 36]. Therefore, changes in
protein backbone dynamics upon ligand introduction
can be used as indicators of the protein–ligand interac-
tion. To test this hypothesis, we measured HDX kinetics
of CRABP under near-native conditions (pH 7, 10 mM
CH3CO2NH4) both in the absence and in the presence of
a range of retinoids (ATRA, 9-cis-RA, 13-cis-RA, and
ROH), Figures 4 and 5. The experiment was conducted
at 36 °C in order to reduce the HDX measurement time
compared to room temperature.
Hydrogen exchange of protons in folded proteins in
solution depends on two processes, one being the
unfolding event which exposes the amide to solvent,
and the other the intrinsic exchange of an exposed
amide with bulk solvent [37]. Under most conditions
(including physiological conditions), protein refolding
rates are much higher than the intrinsic amide exchange
rates (a situation commonly known as the EX2 exchange
regime) [2]. The observed rate equation is
kobs  Kop  kint,
where Kop is the unfolding equilibrium constant and kint
is the intrinsic amide exchange rate constant. This gives
rise to a non-uniform incorporation of deuterium across
the population of protein molecules in solution. As a
consequence, the observed mass spectra will contain a
single peak, gradually shifting in mass as the exchange
time increases.
HDX of CRABP I at pH 7 clearly follows the EX2
exchange mechanism (Figure 4). As expected, the mea-
sured HDX kinetics change dramatically upon intro-
duction of ATRA to the exchange buffer. After 60 min of
exchange, only 34  2 protected deuterons remain in
the apo-form of the protein, whereas in the presence of
Figure 3. ESI mass spectra of CRABP I mixtures with RA isomers
(a) retinoic acid, (b) 13-cis-RA, (c) 9-cis-RA, (d) retinol, and (e) in
the absence of RA isomers. All spectra were collected under the
following conditions: VO-L  60 V, TD  60 °C. The inset is the
enlargement of the intact ion peak at 8 charge state, a variety of
adducts including sodium, potassium and acetate are observed.
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ATRA, some 56  2 amides remain protected. Impor-
tantly, the HDX kinetics in the ATRA–CRABP I system
is not dependent on the ATRA concentration, so long as
molar concentration of the ligand is equal to or exceeds
that of the protein, sufficient to insure saturated bind-
ing. The fraction of protected amides as a function of
the exchange time was measured in a 1:1 ATRA–
CRABP I mixture and was found to be nearly identi-
cal to that measured in the 5:1 mixture (data not
shown).
The other isomers of ATRA do not afford such
significant protection to CRABP I, resulting in only 11
2 (9-cis RA) and 8  2 (13-cis RA) more amides
sequestered from solvent after 1 h of exchange com-
pared to the apo-form of the protein. It is clear, there-
fore, that the presence of both 9- and 13-cis isomers does
reduce the backbone mobility, although not to such a
significant extent as the physiological ligand ATRA.
HDX of CRABP in the presence of ROH is almost
identical to the apo-form, consistent with the notion
that ROH does not bind to CRABP I. This also demon-
strates that protection does not result simply from
non-specific hydrophobic interactions in solution. Thus,
HDX measurements at neutral pH provide correct rank-
ing of the retinoid affinities to CRABP I: ATRA  9-cis
RA  13-cis-RA  retinol (no binding).
To determine the rate constants kobs, the experimen-
tally measured curves representing amide protection as







The following restrictions were applied: (1) a summa-
tion of pre-exponential factors was set to 107 and (2) the
set of pre-exponential factors Ai was the same for both
apo- and holo-forms of the protein. The first restriction
(1) above reflects the fact that there are 107 backbone
amide hydrogen atoms protected (H-bonded) in the
Figure 4. Evolution of a peak shape of a 8 ion of CRABP I undergoing HDX in the absence (grey
line) and in the presence (black line) of five-fold molar excess of ATRA under “near-native” conditions
(pH 6.9, 10 mM NH4CH3CO2). The “zero point” is represented by a spectrum of a fully deuterated
protein in D2O/CD3CO2ND4. The “end point” of the exchange is represented by a spectrum of
unlabeled CRABP I in protiated solution. Protein concentration is 1.2 M, protein/ligand molar ratio
is 1:5. ESI source settings: VO-L  120 V, TD  80 °C.
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native state of both apo- and holo- forms of CRABP I
according to available crystal structures [15, 38]. This
can be demonstrated using ESI-MS by allowing ex-
change to occur under conditions where the intrinsic
amide exchange rate is significantly lower and hence an
initial time point can be measured more readily. At pH
3.5 and 20 °C, the average intrinsic exchange rate is
reduced to as low as 0.005 s1, with a corresponding
half-life of about 2.5 min [39]. Our experiments con-
ducted at pH 3.5 under room temperature show in all
cases the 2 min exchange time point for CRABP I is
identical regardless the presence of ligands, with 107 
3 amides protected, justifying the first restriction above
(data not shown).
The second restriction reflects an implicit assump-
tion that there are a total of n different states of the
protein, including the native state, random coil and n-2
intermediate states whose structures (but not the ener-
getics) are unaffected by the presence of ligand. The
total number of protein states participating in HDX (n)
was determined by deconvolution of charge state dis-
tributions [5]. The same number of states are observed
with the same basis sets regardless of apo-/holo- and
ligand type. This implies that “activated” states, which
may be important for the ligand-binding process, are
similar in apo- and holo-forms and that non-cognate
ligands do not alter the native state structure. This
implies that dissociation of the ligand from the protein
occurs through the same mechanism as binding (al-
though in reverse order). Although this assumption
appears to be reasonable, its validity will be tested in a
later section of this paper.
Curve fitting of the experimental data for the apo-
and holo-forms of the protein (in complex with ATRA)
produced satisfactory results (as judged by randomness
of residuals) only when a tri-exponential decay was
used to model the HDX kinetics (see Table 1). This
suggests that the total number of states is four (imply-
ing two intermediate states can become transiently
populated under native conditions). Figure 6 depicts
hypothetical energy landscapes of the protein with and
without the ligand. The fast phase of the exchange
represents transient formation of a highly structured
intermediate state (I1, 32 fewer protected amides com-
pared to the native state), while the medium phase
represents a transient formation of a less structured
state (I2, 56 fewer protected amides compared to the
native state). The slowest HDX phase represents tran-
sient global unfolding of the protein (U, i.e., formation
of a random coil state with little or no protection).
Interestingly, when HDX of CRABP I (apo-form) was
monitored by NMR, only 71 protected amides were
detected (S.J.E. and L.M. Gierasch, unpublished data).
Our measurements suggest that the transition from the
native state to the highly structured intermediate
(N3 I1) occurs on the time scale of less than 2 min at
36 °C (5 min at 25 °C) and thus these amides would
exchange too rapidly to be detected by NMR. Accord-
ing to our measurements, this transition accounts for a
loss of protection at 30 amide hydrogen atoms, thus
leaving only 77 amides that remain protected on a time
scale readily accessible to 2-D HDX/NMR (30 min).
Assuming that specific binding is the only factor
responsible for modulation of the backbone dynamics,
and that there is no ligand interaction between the
ligand and the fully unstructured protein, we can
provide estimates of the binding energy based on the
measured HDX kinetics. The protein free energy gain
upon unfolding from the native state 	G relates to the
unfolding equilibrium constant in a two-state process
simply as
Figure 5. H/D exchange kinetics of CRABP I in the presence of
ATRA (inverted filled triangle), 9-cis-RA (filled triangle), 13-cis-RA
(filled circle), and in the absence of the ligand (filled square).
Protein concentration 1.2 M (in 10 mM NH4CH3CO2, pH 6.9).
Protein:ligand molar ratio is 1:5. ESI source settings: VO-L  120 V,
TD  80 °C (a). Each curve was fitted with triple-modal exponen-
tial decay function N  30 exp(k1t)  24 exp(k2t)  53
exp(k3t) (calculated k values are shown in Table 1).
Table 1. HDX rates of CRABP I at pH 7 (36 °C)a
Ligand Fast phase (min1) Medium phase (min1) Slow phase (min1)
None 3.291.00 0.0370.002 0.00740.0001
13-cis RA 2.830.63 0.0370.002 0.00440.001
9-cis RA 2.020.27 0.0680.006 0.00250.001
ATRA 1.240.12 0.0350.002 0.000260.00008
aAll the errors are from curve fitting only.
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	G   RT  lnKop (2)
Therefore, one can use the values of Kop (measured in
the absence and in the presence of ATRA) to determine
the change in the protein stability 		G upon introduc-
tion of the ligand into the protein solution, which
should be numerically equal to the protein–ligand bind-
ing energy. The equilibrium constants Kop can be cal-
culated based on the measured HDX kinetics; the dif-
ference in stability of the native conformation can be
calculated as
		G  RT  ln KopapoKopholo (3)
Calculation of 		G3, the free energy difference derived
from the slowest exchange process, based on the exper-
imental data (Table 1) gives 2 kcal/mol as an estimate of
the ATRA–CRABP I binding energy. The calculation is
reasonably close to the stabilization energy measured
calorimetrically, considering the possibility of protein
aggregation under conditions employed in a typical
DSC experiment [16].
The intermediate states are also stabilized in the
presence of the ligand (see Table 2 and Figure 6). Thus,
		G1  0.6 kcal/mol, indicating that the free energy of
the more structured intermediate (I1) decreases by 1.4
kcal/mol in the presence of ATRA. Interestingly, the
less structured intermediate species (I2) appears to be
stabilized in the presence of ATRA by 2 kcal/mol (since
the calculated 		G2  0.03 kcal/mol is close to thermal
energy).
Thermodynamics of 9-cis and 13-cis RA interaction
with CRABP I based on HDX measurements suggest
that CRABP I is stabilized by these two retinoids
although to a lesser extent compared to the cognate
ligand all-trans RA: 		G3  0.6 kcal/mol for 9-cis, and
0.3 kcal/mol for 13-cis RA.
Protein Dynamics and Ligand Binding Under
Mildly Denaturing Conditions: Correlating Ligand
Binding with Specific Dynamic Events
Characterization of the protein backbone flexibility
modulation by ligand under native conditions provides
the most straightforward way to probe binding events
by measuring protein dynamics. However, it is impor-
tant to remember that estimation of 		Gbinding simply
as 		G (based on the measured values of Kop) relies on
an implicit assumption that the conformational changes
upon binding are negligible, i.e., the structure of apo-
and holo-forms are identical. As illustrated in our
hypothetical energy landscape of apo- and holo-form of
the protein (Figure 6), favorable ligand–protein interac-
tions decrease the free energy of the native state of
protein upon ligand binding, without affecting the
native state conformation. Furthermore, the second
restriction of Eq 1 above relies on the assumption that
any structured intermediates which are important for
ligand binding and release remain the same in nature
regardless of the ligand, i.e., a dynamic “lock-and-key”
binding mechanism as opposed to an “induced fit”. We
postulate that ligand-binding may affect the free energy
of the intermediate states without altering their struc-
tures. The free energy of each intermediate should be
decreased to a lesser extent upon ligand binding (com-
pared to the 		G of the native state), since they have
less favorable ligand–protein interactions. The crystal
structures of the ligand-free and bound forms of the
Figure 6. A diagram of hypothetical energy landscapes of CRABP I in the apo- (left) and holo- (right)
forms. Both intermediate states and the native state are stabilized in the presence of the ligand.
Table 2. Analysis of HDX curves for CRABP I in the absence







13-cis RA 0.09 – 0.3
9-cis RA 0.3 – 0.6
ATRA 0.6 0.03 2
512 XIAO ET AL. J Am Soc Mass Spectrom 2003, 14, 506–515
native state are effectively identical [15], but there is no
direct evidence to demonstrate the similarity of tran-
sient partially folded conformers. In fact, one might
argue that accommodation of RA isomers within the
binding cavity of CRABP I may induce significant local
conformational alterations. Therefore, in order to vali-
date the measurements presented in the previous sec-
tion, one needs to prove that ligand-binding (ATRA or
its isomers) does not induce any conformational
changes within the protein, but simply shifts the equi-
libria among the conformers already present in the
apo-form of the protein. We have demonstrated previ-
ously that the distribution of protein ion charge states in
ESI-MS under native and mildly denaturing conditions
can give clear indications as to the number and nature
of the states present in solution [5]. Thus, we undertook
a detailed analysis of the charge state distributions
exhibited by CRABP I ions in the apo-form and in the
presence of the various ligands.
As shown in Figure 7, the spectrum of CRABP I at
neutral pH shows a very narrow distribution of charge
states (ranging from 7 to 9). A distribution with
higher charge states (low m/z) appears at lower pH,
owing to the ability of unfolded protein molecules to
accommodate charges more readily than the folded
protein. Importantly, the protein–ligand complex ions
become significantly less abundant below pH 5, and yet
the ATRA–CRABP I complex ions can be observed as
low as pH 3. It is notable that only ion peaks of lower
charge states (from 7 to 9) contain the protein–
ligand complex form, whereas only ion peaks corre-
sponding to the ligand-free form were observed in the
higher charge states. Interestingly, the spectra contain
no evidence that the binding-competent intermediate
states of the protein (I1 and I2) form stable complexes
with the ligand, although the HDX measurements car-
ried out under native conditions indicate some stabili-
zation of the two intermediate states induced by ligand
binding. This suggests that these complexes are too
unstable to be observed directly under the ESI source
conditions employed here.
Onset of protein unfolding is observed in the pres-
ence of ligand between pH 4.5 and 4. At pH 4.5 and
above, the high charge density protein ions are absent
from the mass spectra of CRABP I in the presence of
retinoids. In the apo-form, however, this unfolded
distribution persists, providing further evidence that
ligand binding stabilizes the protein by effectively in-
hibiting sampling of the more unfolded ensembles.
Importantly, the order of binding preferences of retin-
oids to the protein’s native conformation remains un-
changed throughout the entire pH range studied.
The fraction of ligand-bound protein ions is plotted
versus pH in Figure 8, where the relative intensities of
the protein–ligand complex ions were monitored as a
function of pH. The peak intensities for the most
abundant ion peaks (8) of the apo-protein and pro-
tein–ligand complex were compared to determine the
fraction of protein–ligand complex ion at each pH.
There is a sharp decrease in the intensity of the ligand-
bound protein ions at pH 
 4.5, with the midpoint of
the transition occurring at about pH 4. The onset of
Figure 7. Charge state distribution of CRABP I with and without ligand: ATRA (a), 9-cis-RA–CRABP
(b), and apo-protein (c). ESI interface conditions: VO-L  60 V, TD  60 °C.
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unfolding of the protein in the ATRA–CRABP I mix-
ture, on the other hand, occurs only below pH 4. It is
probable that disappearance of the holo-form from the
spectra results from RA protonation if its pKa is within
this pH range (the isomeric form isotretinoin has a pKa
of 3.8 [40]), followed by protein denaturation as the pH
is further reduced. The less cooperative nature of the
binding curve for the CRABP-9-cis-RA (and to a lesser
extent 13-cis-RA) complex suggests relatively weak
binding between protein and 9-cis or 13-cis RA relative
to the all-trans form.
Conclusions
In this paper we have demonstrated that additional
protection against amide hydrogen exchange af-
forded by binding of small hydrophobic ligands to
CRABP I may be used to determine the efficacy of
ligand-binding, thus enabling an order of binding
preference to be measured. Retinoic acid does not
form hydrogen bonds to the peptide backbone of the
protein, hence all “ligand-induced” protection can be
attributed to reduced protein flexibility. By compar-
ing the protein hydrogen exchange behaviors in the
presence of ligands with gradually reduced binding
affinities, we are able to determine the ligand-binding
effect on protein conformational dynamics. Protec-
tion against exchange of CRABP I in the presence of
13-cis- and 9-cis-RA is lower relative to that in the
presence of all-trans-RA, consistent with the order of
binding affinity to the protein. The binding prefer-
ence of retinoids to CRABP I has the order of all-
trans-RA  9-cis-RA  13-cis-RA, as determined by
our HDX/MS measurements, which is in agreement
with the solution-based fluorimetric measurements.
This method is more accurate than traditional direct
ESI MS measurements and may be used to extract the
protein–ligand binding energy. In the presence of
retinol, the protein is no more protected against
exchange than the apo-form itself, thus demonstrat-
ing that the protein neither binds this ligand specifi-
cally, nor is exchange affected by non-specific inter-
actions.
The exchange kinetics exhibit multiple rate con-
stants, indicating that the exchange occurs not only
upon complete unfolding of the protein, but also a
number of partially folded “activated” states are in-
volved in this process. Exchange from these states is
also affected by the presence of RA, suggesting that the
ligand is also associated with these conformers. A
detailed analysis of the charge state distributions under
native and mildly denaturing conditions demonstrates
that these activated states are populated to varying
extents under all conditions. We postulate that these
conformers are important mechanistically for the li-
gand-binding process, since the native state itself (as
judged from the crystal structure) does not have an
opening sufficient to allow ligand access to the binding
cavity [38].
By performing exchange experiments on CRABP I in
the presence of ligand but under mildly denaturing
conditions, we can increase the Boltzmann weight of
these partially folded conformers and, using HDX
ESI-MS under conditions favoring the EX1 regime, we
can measure protection in these individual states [20].
This unique capability of mass spectrometry to distin-
guish protection in each state will shed light on the
dynamic processes associated with ligand binding. In
combination with fragmentation methods and FT ICR
MS [21], we also plan to determine site-specifically the
regions of the protein important for ligand-binding
specificity.
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